Hence, we utilized a human TNBC xenograft model in NSG mice, which explicitly demonstrated the superior anti-tumor effect of the 5-FU-curcumin combination, which specifically leads to the down-regulation of TS pathway. The gene discussed is TYMS; the disease is neoplasm.